Oxacillin Sodium

ANDA 62252, held by Chartwell Rx. Oxacillin Sodium.

As of Nov 15, 2026, ANDA 62252 (Oxacillin Sodium), held by Chartwell Rx, was first approved by FDA on May 15, 1980, with 5 approved supplements and 0 published complete response letters.

First approved: May 15, 1980
Supplements approved: 5
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 6 submissions below

Date	Submission	Status	Documents
May 15, 1980	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Oxacillin SodiumEQ 250MG BASE/5ML · for solution;oral	Oxacillin Sodium	Discontinued

All 6 submissions, including labeling and manufacturing supplements


Jul 7, 2000	Supplement 5Manufacturing	Approved	None posted
Dec 22, 1997	Supplement 4Manufacturing	Approved	None posted
Aug 19, 1997	Supplement 3Manufacturing	Approved	None posted
Aug 30, 1996	Supplement 2Manufacturing	Approved	None posted
Dec 22, 1994	Supplement 1Manufacturing	Approved	None posted
May 15, 1980	Original application	Approved	None posted

Identifiers

Application: ANDA 62252
Drugs@FDA: Overview at FDA
Company: Chartwell RX

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters